相关实验视频

Updated: May 12, 2025

An Experimental Paradigm for the Prediction of Post-Operative Pain PPOP

An Experimental Paradigm for the Prediction of Post-Operative Pain PPOP

Published on: January 27, 2010

单核酸多态性是否会影响小儿脊椎病纠正手术后的疼痛强度和sufentanil止痛?

Aleksander Turczynowicz¹, Jakub Równy¹, Weronika Przontka¹

¹Department of Anesthesiology and Intensive Care for Children and Adolescents with Postoperative and Pain Treatment Unit, Medical University of Bialystok, 15-274 Bialystok, Poland.

International journal of molecular sciences

|May 7, 2025

概括

单核酸多态 (SNP) 可以影响儿科术后疼痛. ADRB1 rs1801253 SNP可能表明疼痛风险和阿片类药物需求较高,而CRP和ABCB1 SNP可以预测护理需求.

科学领域:

药物基因组学药物基因组学
儿科麻醉学儿科麻醉学
疼痛管理疼痛管理

背景情况:

儿科术后疼痛评估具有挑战性,依赖于主观措施.
单核酸多态 (SNP) 可能会影响个体的疼痛值和阿片类药物代谢.
识别遗传标记可以提高儿童疼痛管理策略.

研究的目的:

调查9个特定SNP与儿科患者手术后疼痛结果之间的关联.
探索这些SNP对疼痛强度,阿片类药物消耗和麻醉后护理单位 (PACU) 停留时间的影响.
为了确定遗传变异是否可以预测儿童急性疼痛管理需求.

主要方法:

使用实时PCR对9个SNP (包括ADRB1,CRP,ABCB1,OPRM1,COMT,ENPP2) 进行基因型鉴定.
分析术后疼痛强度 (NRS),苏芬坦尼尔需求,辅助止痛药的使用,CRP水平和PACU停留时间.
研究队列包括42名小儿科患者,他们接受了用sufentanil输注进行脊椎病修正手术.

主要成果:

ADRB1 rs1801253 GG基因型与24小时疼痛评级较低以及减少sufentanil需求的趋势有关.
CRP rs1205 CT基因型与较短的PACU停留时间相关.
ABCB1 rs1045642 GG基因型与更长的PACU停留时间有关.

结论:

ADRB1 rs1801253可以作为儿童手术后疼痛和阿片类药物需求增加的预测标志物.
CRP rs1205和ABCB1 rs1045642 SNP可以帮助预测PACU中不同的护理需求.
将SNP分析纳入急性疼痛评估可能会个性化并改善儿科疼痛管理.

关键词:

在ADRB1中,它是ADRB1.科姆特 (COMT) 是一个有价值的项目.在OPRM1中使用OPRM.在SNP中,SNP是SNP.阿片类药物代谢阿片类药物代谢疼痛的强度,疼痛的强度.术后疼痛术后疼痛术后疼痛一个核酸的多态性.有足够的乙.

更多相关视频

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery

Published on: January 18, 2018

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

相关概念视频

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...